Asmanex
Product Images NDC 54868-5547

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Asmanex (NDC 54868-5547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (220 mcg package label)

The product is called "ASHANEK THIST 226HCG INHALER" with a lot number "b 6gop" and an expiration date of "01/60". It is distributed by "PHYSICIANS TOTAL CARE" and has an NDC code of "54868-5547-1". The text at the bottom "I llIlIIlIIIIIIIII[IIIIIIIIIIIIIIIIIIIII\I" and "55470300000" are not readable and do not provide any useful information.*

FDA Label Image

Chemical Structure (Asmanex 01)

FDA Label Image

Figure (Asmanex 02)

FDA Label Image

Figure (Asmanex 03)

Figure 2 shows the result of a 12-week trial in patients who were already on inhaled corticosteroids and the mean change in FEV (in liters) after using Asmanex Twisthaler in comparison to placebo. The trial included different dosages of Asmanex, such as 220mcg once daily, 440mcg once daily, and 220mcg twice daily, as well as a placebo group. The results indicated a significant improvement in FEV in patients using Asmanex compared to placebo.*

FDA Label Image

Figure (Asmanex 04)

Figure 3 shows the results of a 12-week trial in children ages 4 to 11 regarding the percent-predicted FEV. The graph illustrates the change from the baseline over time and at the endpoint, categorized by treatment group. The mean change in % predicted FEV is shown for Phesbo and Femwex 10mcg. The evaluation includes Baseline, Day 4, Week 1, Week 2, Week 4, Week 8, Week 12, and Endpoint data. The endpoint refers to the last available data for each subject.*

FDA Label Image

Figure (Asmanex 05)

The text is a description of two figures related to an inhaler. The first figure is the inhaler in an upright position and the second figure is the inhaler with its cap removed.*

FDA Label Image

Figure (Asmanex 06)

This text provides instructions on how to use an inhaler. It advises the user to hold the inhaler in an upright position and twist the cap counterclockwise to open it. The figure shows how removing the cap loads the dose.*

FDA Label Image

Figure (Asmanex 07)

The text explains about ventilation holes and gives a warning not to cover them while inhaling the dose. It also references Figure 4, which could be a diagram or image related to inhalation.*

FDA Label Image

Figure (Asmanex 08)

This text provides instructions for closing and properly loading the Tnhaler inhaler. The text explains how to align the Indented Arrow with the Dose Counter, how to replace the cap and turn it clockwise until it clicks, and how to listen for the click to ensure the cap is fully closed. Following these steps is the only way to properly load the inhaler and ensure the next dose is loaded correctly. There is also a labeled diagram of the inhaler to assist with the instructions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.